Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 178

1.

Optimizing HIV prevention and treatment outcomes for persons with substance use in Central Asia: what will it take?

Deryabina AP, El-Sadr WM.

Curr Opin HIV AIDS. 2019 Sep;14(5):374-380. doi: 10.1097/COH.0000000000000565.

PMID:
31219889
2.

Brief Report: Durability of the Effect of Financial Incentives on HIV Viral Load Suppression and Continuity in Care: HPTN 065 Study.

El-Sadr WM, Beauchamp G, Hall HI, Torian LV, Zingman BS, Lum G, Elion RA, Buchacz K, Burns D, Zerbe A, Gamble T, Donnell DJ; HPTN 065 Study.

J Acquir Immune Defic Syndr. 2019 Jul 1;81(3):300-303. doi: 10.1097/QAI.0000000000001927.

3.

AIDS in America - Back in the Headlines at Long Last.

El-Sadr WM, Mayer KH, Rabkin M, Hodder SL.

N Engl J Med. 2019 May 23;380(21):1985-1987. doi: 10.1056/NEJMp1904113. Epub 2019 May 1. No abstract available.

PMID:
31042822
4.

Host country responses to non-communicable diseases amongst Syrian refugees: a review.

Akik C, Ghattas H, Mesmar S, Rabkin M, El-Sadr WM, Fouad FM.

Confl Health. 2019 Mar 22;13:8. doi: 10.1186/s13031-019-0192-2. eCollection 2019. Review.

5.

Strengthening the Quality and Quantity of the Nursing and Midwifery Workforce: Report on Eight Years of the NEPI Project.

Michaels-Strasser S, Smith J, Khanyola J, Sutton R, Price T, El Sadr WM.

Ann Glob Health. 2018 Apr 30;84(1):31-35. doi: 10.29024/aogh.6.

PMID:
30873797
6.

Underreported injection drug use and its potential contribution to reported increase in sexual transmission of HIV in Kazakhstan and Kyrgyzstan.

Deryabina AP, Patnaik P, El-Sadr WM.

Harm Reduct J. 2019 Jan 5;16(1):1. doi: 10.1186/s12954-018-0274-2.

7.

Where are the positives? HIV testing in sub-Saharan Africa in the era of test and treat.

De Cock KM, Barker JL, Baggaley R, El Sadr WM.

AIDS. 2019 Feb 1;33(2):349-352. doi: 10.1097/QAD.0000000000002096. No abstract available.

PMID:
30557162
8.

Persons living with HIV with advanced HIV disease: need for novel care models.

Teasdale CA, Yuengling K, Preko P, Syowai M, Ndagije F, Rabkin M, Abrams EJ, El-Sadr WM.

J Int AIDS Soc. 2018 Dec;21(12):e25210. doi: 10.1002/jia2.25210.

9.

Correction to: China's health assistance to Africa: opportunism or altruism?

Lin S, Gao L, Reyes M, Cheng F, Kaufman J, El-Sadr WM.

Global Health. 2018 Oct 1;14(1):95. doi: 10.1186/s12992-018-0411-4.

10.

Response Rates of Medical Providers to Internet Surveys Regarding Their Adoption of Preexposure Prophylaxis for HIV: Methodological Implications.

Silverman TB, Schrimshaw EW, Franks J, Hirsch-Moverman Y, Ortega H, El-Sadr WM, Colson PW.

J Int Assoc Provid AIDS Care. 2018 Jan-Dec;17:2325958218798373. doi: 10.1177/2325958218798373.

11.

Cost-effectiveness of a combination strategy to enhance the HIV care continuum in Swaziland: Link4Health.

Stevens ER, Li L, Nucifora KA, Zhou Q, McNairy ML, Gachuhi A, Lamb MR, Nuwagaba-Biribonwoha H, Sahabo R, Okello V, El-Sadr WM, Braithwaite RS.

PLoS One. 2018 Sep 17;13(9):e0204245. doi: 10.1371/journal.pone.0204245. eCollection 2018.

12.

HIV Care Continuum in Adults and Children: Cost-Effectiveness Considerations.

Harripersaud K, McNairy M, Ahmed S, Abrams EJ, Thirumurthy H, El-Sadr WM.

In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 4.

13.

Tuberculosis preventive treatment preferences among care givers of children in Lesotho: a pilot study.

Hirsch-Moverman Y, Mantell JE, Lebelo L, Wynn C, Hesseling AC, Howard AA, Nachman S, Frederix K, Maama LB, El-Sadr WM.

Int J Tuberc Lung Dis. 2018 Aug 1;22(8):858-862. doi: 10.5588/ijtld.17.0809.

PMID:
29991393
14.

Building on the HIV chronic care platform to address noncommunicable diseases in sub-Saharan Africa: a research agenda.

Vorkoper S, Kupfer LE, Anand N, Patel P, Beecroft B, Tierney WM, Ferris R, El-Sadr WM; HIV/NCD Project.

AIDS. 2018 Jul 1;32 Suppl 1:S107-S113. doi: 10.1097/QAD.0000000000001898.

15.

Integrating cardiovascular disease risk factor screening into HIV services in Swaziland: lessons from an implementation science study.

Rabkin M, Palma A, McNairy ML, Gachuhi AB, Simelane S, Nuwagaba-Biribonwoha H, Bongomin P, Okello VJ, Bitchong RA, El-Sadr WM.

AIDS. 2018 Jul 1;32 Suppl 1:S43-S46. doi: 10.1097/QAD.0000000000001889.

16.

Building on the HIV platform: tackling the challenge of noncommunicable diseases among persons living with HIV.

El-Sadr WM, Goosby E.

AIDS. 2018 Jul 1;32 Suppl 1:S1-S3. doi: 10.1097/QAD.0000000000001886.

PMID:
29952785
17.

In Memoriam, Fred Gordin, MD, 1951-2018.

Cohn DL, El Sadr WM, Abrams DI, Neaton JD, Benator DA, Vernon AA.

Clin Infect Dis. 2018 Jun 18;67(1):153. doi: 10.1093/cid/ciy338. No abstract available.

PMID:
29846556
18.

HIV Population Surveys - Bringing Precision to the Global Response.

Justman JE, Mugurungi O, El-Sadr WM.

N Engl J Med. 2018 May 17;378(20):1859-1861. doi: 10.1056/NEJMp1801934. No abstract available.

19.

Achieving the fourth 90: healthy aging for people living with HIV.

Harris TG, Rabkin M, El-Sadr WM.

AIDS. 2018 Jul 31;32(12):1563-1569. doi: 10.1097/QAD.0000000000001870. No abstract available.

20.

A time-motion study of cardiovascular disease risk factor screening integrated into HIV clinic visits in Swaziland.

Palma AM, Rabkin M, Simelane S, Gachuhi AB, McNairy ML, Nuwagaba-Biribonwoha H, Bongomin P, Okello VN, Bitchong RA, El-Sadr WM.

J Int AIDS Soc. 2018 Mar;21(3):e25099. doi: 10.1002/jia2.25099.

21.

Multiple strategies to identify HIV-positive black men who have sex with men and transgender women in New York City: a cross-sectional analysis of recruitment results.

Franks J, Mannheimer SB, Hirsch-Moverman Y, Hayes-Larson E, Colson PW, Ortega H, El-Sadr WM.

J Int AIDS Soc. 2018 Mar;21(3). doi: 10.1002/jia2.25091.

22.

It's all in the timing: Acceptability of a financial incentive intervention for linkage to HIV care in the HPTN 065 (TLC-Plus) study.

Shelus V, Taylor J, Greene E, Stanton J, Pack A, Tolley EE, Branson BM, El-Sadr WM, Pollydore J, Gamble T.

PLoS One. 2018 Feb 2;13(2):e0191638. doi: 10.1371/journal.pone.0191638. eCollection 2018.

23.

Patient-level and program-level monitoring and evaluation of differentiated service delivery for HIV: a pragmatic and parsimonious approach is needed.

Reidy WJ, Rabkin M, Syowai M, Schaaf A, El-Sadr WM.

AIDS. 2018 Jan 28;32(3):399-401. doi: 10.1097/QAD.0000000000001723. No abstract available.

24.

Factors Associated with Use of Short-Term Pre-Exposure Prophylaxis for HIV Among Female Partners of Migrant Miners in Mozambique.

Falcao J, Zerbe A, Lahuerta M, Baggaley R, Ahoua L, DiMattei P, Morales F, Ramiro I, El-Sadr WM.

AIDS Patient Care STDS. 2017 Dec;31(12):528-534. doi: 10.1089/apc.2017.0179.

PMID:
29211515
25.

Expanding Hospital Human Immunodeficiency Virus Testing in the Bronx, New York and Washington, District of Columbia: Results From the HPTN 065 Study.

Branson BM, Chavez PR, Hanscom B, Greene E, McKinstry L, Buchacz K, Beauchamp G, Gamble T, Zingman BS, Telzak E, Naab T, Fitzpatrick L, El-Sadr WM; HIV Prevention Trials Network (HPTN) 065 Study Team.

Clin Infect Dis. 2018 May 2;66(10):1581-1587. doi: 10.1093/cid/cix1053.

26.

Selecting a viral load threshold for routine monitoring in resource-limited settings: optimizing individual health and population impact.

Ellman TM, Alemayehu B, Abrams EJ, Arpadi S, Howard AA, El-Sadr WM.

J Int AIDS Soc. 2017 Nov;20 Suppl 7. doi: 10.1002/jia2.25007. No abstract available.

27.

The PREVENT study to evaluate the effectiveness and acceptability of a community-based intervention to prevent childhood tuberculosis in Lesotho: study protocol for a cluster randomized controlled trial.

Hirsch-Moverman Y, Howard AA, Frederix K, Lebelo L, Hesseling A, Nachman S, Mantell JE, Lekhela T, Maama LB, El-Sadr WM.

Trials. 2017 Nov 21;18(1):552. doi: 10.1186/s13063-017-2184-0.

28.

Realizing the potential of routine viral load testing in sub-Saharan Africa.

El-Sadr WM, Rabkin M, Nkengasong J, Birx DL.

J Int AIDS Soc. 2017 Nov;20 Suppl 7. doi: 10.1002/jia2.25010. No abstract available.

29.

Effectiveness of a combination strategy for linkage and retention in adult HIV care in Swaziland: The Link4Health cluster randomized trial.

McNairy ML, Lamb MR, Gachuhi AB, Nuwagaba-Biribonwoha H, Burke S, Mazibuko S, Okello V, Ehrenkranz P, Sahabo R, El-Sadr WM.

PLoS Med. 2017 Nov 7;14(11):e1002420. doi: 10.1371/journal.pmed.1002420. eCollection 2017 Nov.

30.

Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study.

Boyd MA, Mocroft A, Ryom L, Monforte AD, Sabin C, El-Sadr WM, Hatleberg CI, De Wit S, Weber R, Fontas E, Phillips A, Bonnet F, Reiss P, Lundgren J, Law M.

PLoS Med. 2017 Nov 7;14(11):e1002424. doi: 10.1371/journal.pmed.1002424. eCollection 2017 Nov.

31.

Reaching global HIV/AIDS goals: What got us here, won't get us there.

El-Sadr WM, Harripersaud K, Rabkin M.

PLoS Med. 2017 Nov 7;14(11):e1002421. doi: 10.1371/journal.pmed.1002421. eCollection 2017 Nov.

32.

A Randomized-Controlled Trial of Computer-based Prevention Counseling for HIV-Positive Persons (HPTN 065).

McKinstry LA, Zerbe A, Hanscom B, Farrior J, Kurth AE, Stanton J, Li M, Elion R, Leider J, Branson B, El-Sadr WM.

J AIDS Clin Res. 2017 Jul;8(7). pii: 714. doi: 10.4172/2155-6113.1000714. Epub 2017 Jul 26.

33.

Advanced Human Immunodeficiency Virus Disease at Diagnosis in Mozambique and Swaziland.

Kujawski SA, Lamb MR, Lahuerta M, McNairy ML, Ahoua L, Abacassamo F, Nuwagaba-Biribonwoha H, Gachuhi A, El-Sadr WM, Elul B.

Open Forum Infect Dis. 2017 Jul 23;4(3):ofx156. doi: 10.1093/ofid/ofx156. eCollection 2017 Summer. Erratum in: Open Forum Infect Dis. 2018 Jan 30;5(1):ofx191.

34.

Pregnant and breastfeeding women: A priority population for HIV viral load monitoring.

Myer L, Essajee S, Broyles LN, Watts DH, Lesosky M, El-Sadr WM, Abrams EJ.

PLoS Med. 2017 Aug 15;14(8):e1002375. doi: 10.1371/journal.pmed.1002375. eCollection 2017 Aug.

35.

Limited awareness of pre-exposure prophylaxis among black men who have sex with men and transgender women in New York city.

Garnett M, Hirsch-Moverman Y, Franks J, Hayes-Larson E, El-Sadr WM, Mannheimer S.

AIDS Care. 2018 Jan;30(1):9-17. doi: 10.1080/09540121.2017.1363364. Epub 2017 Aug 9.

36.

Uptake of needle and syringe program services in the Kyrgyz Republic: Key barriers and facilitators.

Deryabina A, El-Sadr WM.

Drug Alcohol Depend. 2017 Oct 1;179:180-186. doi: 10.1016/j.drugalcdep.2017.07.002. Epub 2017 Aug 2.

PMID:
28787695
37.

Feasibility, Acceptability, and Adherence with Short-Term HIV Preexposure Prophylaxis in Female Sexual Partners of Migrant Miners in Mozambique.

Lahuerta M, Zerbe A, Baggaley R, Falcao J, Ahoua L, DiMattei P, Morales F, Ramiro I, El-Sadr WM.

J Acquir Immune Defic Syndr. 2017 Dec 1;76(4):343-347. doi: 10.1097/QAI.0000000000001518.

38.

The science of Durban, AIDS 2016.

Beyrer C, Shisana O, Baral SD, Milsana K, Mayer KH, Pozniak A, Walker BD, Mboup S, Sohn AH, Serwadda D, Rees H, Dvoriak S, Warren M, Thiam S, El-Sadr WM, Hospital X, Ryan O, Thomson N, Bekker LG.

J Int AIDS Soc. 2017 Jun 30;20(1):21781. doi: 10.7448/IAS.20.1.21781.

39.

Use of Index Patients to Enable Home-Based Testing in Lesotho.

DiCarlo A, Zerbe A, Peters ZJ, Frederix K, Nkonyana JP, Mantell JE, Remien RH, El-Sadr WM.

J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):e61-e64. doi: 10.1097/QAI.0000000000001486. No abstract available.

PMID:
28639992
40.

Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients: A Randomized Clinical Trial (HPTN 065).

El-Sadr WM, Donnell D, Beauchamp G, Hall HI, Torian LV, Zingman B, Lum G, Kharfen M, Elion R, Leider J, Gordin FM, Elharrar V, Burns D, Zerbe A, Gamble T, Branson B; HPTN 065 Study Team.

JAMA Intern Med. 2017 Aug 1;177(8):1083-1092. doi: 10.1001/jamainternmed.2017.2158.

41.

Design of the HPTN 065 (TLC-Plus) study: A study to evaluate the feasibility of an enhanced test, link-to-care, plus treat approach for HIV prevention in the United States.

Gamble T, Branson B, Donnell D, Hall HI, King G, Cutler B, Hader S, Burns D, Leider J, Wood AF, G Volpp K, Buchacz K, El-Sadr WM; HPTN 065 Study Team.

Clin Trials. 2017 Aug;14(4):322-332. doi: 10.1177/1740774517711682. Epub 2017 Jun 19.

42.

The Role of Financial Incentives Along the Antiretroviral Therapy Adherence Continuum: A Qualitative Sub-study of the HPTN 065 (TLC-Plus) Study.

Tolley EE, Taylor J, Pack A, Greene E, Stanton J, Shelus V, Dunner R, Hodge T, Branson B, El-Sadr WM, Gamble T.

AIDS Behav. 2018 Jan;22(1):245-257. doi: 10.1007/s10461-017-1821-7.

43.

Nurse-led HIV services and quality of care at health facilities in Kenya, 2014-2016.

Rabkin M, Lamb M, Osakwe ZT, Mwangi PR, El-Sadr WM, Michaels-Strasser S.

Bull World Health Organ. 2017 May 1;95(5):353-361. doi: 10.2471/BLT.16.180646. Epub 2017 Apr 5.

44.

Clinical decision tools are needed to identify HIV-positive patients at high risk for poor outcomes after initiation of antiretroviral therapy.

McNairy ML, Abrams EJ, Rabkin M, El-Sadr WM.

PLoS Med. 2017 Apr 18;14(4):e1002278. doi: 10.1371/journal.pmed.1002278. eCollection 2017 Apr.

45.

Community health worker perspectives on a new primary health care initiative in the Eastern Cape of South Africa.

Austin-Evelyn K, Rabkin M, Macheka T, Mutiti A, Mwansa-Kambafwile J, Dlamini T, El-Sadr WM.

PLoS One. 2017 Mar 16;12(3):e0173863. doi: 10.1371/journal.pone.0173863. eCollection 2017.

46.

"It Makes You Feel Like Someone Cares" acceptability of a financial incentive intervention for HIV viral suppression in the HPTN 065 (TLC-Plus) study.

Greene E, Pack A, Stanton J, Shelus V, Tolley EE, Taylor J, El Sadr WM, Branson BM, Leider J, Rakhmanina N, Gamble T.

PLoS One. 2017 Feb 9;12(2):e0170686. doi: 10.1371/journal.pone.0170686. eCollection 2017.

47.

Task-sharing with nurses to enhance access to HIV treatment in Côte d'Ivoire.

McNairy ML, Bashi JB, Chung H, Wemin L, Lorng MA, Brou H, Nioble C, Lokossue A, Abo K, Achi D, Ouattara K, Sess D, Sanogo PA, Ekra A, Ettiegne-Traore V, Diabate CJ, Abrams EJ, El-Sadr WM.

Trop Med Int Health. 2017 Apr;22(4):431-441. doi: 10.1111/tmi.12839. Epub 2017 Feb 23.

48.

Can the Success of HIV Scale-Up Advance the Global Chronic NCD Agenda?

Palma AM, Rabkin M, Nuwagaba-Biribonwoha H, Bongomin P, Lukhele N, Dlamini X, Kidane A, El-Sadr WM.

Glob Heart. 2016 Dec;11(4):403-408. doi: 10.1016/j.gheart.2016.10.012. Review.

49.

China's health assistance to Africa: opportunism or altruism?

Lin S, Gao L, Reyes M, Cheng F, Kaufman J, El-Sadr WM.

Global Health. 2016 Dec 3;12(1):83. doi: 10.1186/s12992-016-0217-1. Review. Erratum in: Global Health. 2018 Oct 1;14(1):95.

50.

Swaziland HIV Incidence Measurement Survey (SHIMS): a prospective national cohort study.

Justman J, Reed JB, Bicego G, Donnell D, Li K, Bock N, Koler A, Philip NM, Mlambo CK, Parekh BS, Duong YT, Ellenberger DL, El-Sadr WM, Nkambule R.

Lancet HIV. 2017 Feb;4(2):e83-e92. doi: 10.1016/S2352-3018(16)30190-4. Epub 2016 Nov 16.

Supplemental Content

Loading ...
Support Center